Homology Medicines Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Homology Medicines Inc
TickerQTTB
CIK #0001661998
CUSIP746964105
SectorLife Sciences - Pharmaceutical Preparations
Address45 Wiggins Ave, Bedford, MA 01730
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Homology Medicines Inc 2017-08-10 83.5 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001661998] 10-K
[0001661998] 10-Q
[0001661998] 3
[0001661998] 4
[0001661998] 8-K
[0001661998] D
[0001661998] SC 13D
[0001661998] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Boxer Capital Management LLC Q32 Bio Inc [2026-07-10] 0.0
Biotechnology Value Fund L P Q32 Bio Inc [2026-06-04] 0.0
RA Capital Management LP Q32 Bio Inc [2026-06-04] 0.0
Sirenia Capital Management LP Q32 Bio Inc [2026-05-15] 0.0
Opaleye Management Inc Q32 Bio Inc [2026-02-20] 0.0
Point72 Asset Management LP Q32 Bio Inc [2026-02-19] 0.0
SIO Capital Management LLC Q32 Bio Inc [2025-04-08] 0.0
SIO Capital Management LLC Q32 Bio Inc [2025-02-10] 0.0
Bristol Myers Squibb Co Q32 Bio Inc [2024-11-13] 6.23
Acorn BioVentures LP Q32 Bio Inc [2024-04-04] 6.7
Atlas Venture Fund X LP Q32 Bio Inc [2024-04-01] 7.2
Carlyle Group Inc Q32 Bio Inc [2024-03-29] 9.2
OrbiMed Advisors LLC Q32 Bio Inc [2024-03-28] 18.9
ADAR1 Partners LP Homology Medicines Inc [2024-03-14] 0.0
BlackRock Inc Homology Medicines Inc [2022-07-08] 2.9
BlackRock Inc Homology Medicines Inc [2021-02-02] 6.1
Pfizer Inc Homology Medicines Inc [2020-11-19] 0.9
Price T Rowe Associates Inc /MD/ Homology Medicines Inc [2020-02-14] 6.3
RTW Investments LP Homology Medicines Inc [2019-12-30] 8.82
Arch Venture Fund VIII LP Homology Medicines Inc [2019-02-14] 16.2
FMR LLC Homology Medicines Inc [2019-02-13] 0.0
5AM Ventures IV LP Homology Medicines Inc [2019-02-13] 15.7
Novartis Institutes for Biomedical Research Inc Homology Medicines Inc [2019-02-04] 5.3
JPMorgan Chase & Co Homology Medicines Inc [2019-01-10] 5.9
Temasek Holdings Private Ltd Homology Medicines Inc [2018-04-11] 8.6
Flynn James E Homology Medicines Inc [2018-04-06] 6.98
Form 3/4/5 Filer 2011 - 2026
Manke Isaac
Q32 Bio Inc
Laporte Kathleen
Iwicki Mark T
Tzianabos Arthur
Grayzel David S
Thistle Mary
Xu Diyong
Lundberg Sven Ante
Atlas Venture Opportunity Fund Ill LP
Atlas Venture Associates Opportunity III LP
Atlas Venture Associates Opportunity III LLC
OrbiMed Genesis GP LLC
OrbiMed Advisors LLC
OrbiMed Capital GP VII LLC
Morrison Jodie Pope
Kalowski Lee
Violette Shelia M
Campagna Jason
Alloway Paul
Michaud Charles Jr
Atlas Venture Fund X LP
Atlas Venture Opportunity Fund II LP
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
Atlas Venture Associates X LLC
Atlas Venture Associates X LP
Atlas Venture Opportunity Fund I LP
Atlas Venture Associates Opportunity I LLC
Atlas Venture Associates Opportunity I LP
Seymour Albert
Jordan Julie
Poulton Jeffrey V
Reicin Alise
Patterson Matthew R
Gillis Steven
Blum Michael Lee
Smith W Bradford
Gregory Richard J
Parmar Kush
Kelly Timothy P
Cohn Gabriel
5AM Ventures IV LP
5AM Partners IV LLC
5AM Co-Investors IV LP
Schwab Andrew J
Diekman John D
Rocklage Scott M
Deerfield Mgmt HIF LP
Deerfield Management Company LP
Deerfield Mgmt III LP
Deerfield Capital LP
Deerfield Private Design Fund III LP
Deerfield Partners LP
Deerfield Healthcare Innovations Fund LP
Flynn James E
Rasty Siyamak
Wheeler Cameron
Arch Venture Partners VIII LP
Bybee Clinton
Arch Venture Partners VIII LLC
Nelsen Robert
Arch Venture Fund VIII Overage LP
Arch Venture Fund VIII LP
Crandell Keith
TLS Beta Pte Ltd
Temasek Life Sciences Private Ltd
V-Sciences Investments Pte Ltd
Fullerton Management Pte Ltd
Temasek Holdings Private Ltd
Novartis AG
Novartis Institutes for BioMedical Research Inc
Shah Mahendra
VV Manager LLC
Vida Ventures LLC
Rock Springs Capital LLC
Rock Springs Capital Management LP
Rock Springs Capital Master Fund LP
Chatterjee Saswati
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kalowski Lee
Common Stock
2026-02-25 Sell 3,995 $4.51 18,017
Violette Shelia M
Common Stock
2026-02-25 Sell 2,815 $4.51 12,696
Morrison Jodie Pope
Common Stock
2026-02-25 Sell 9,896 $4.51 44,631
Kalowski Lee
Common Stock
2026-02-24 Grant 53,250 $0.00
Morrison Jodie Pope
Common Stock
2026-02-24 Grant 132,000 $0.00
Violette Shelia M
Common Stock
2026-02-24 Grant 37,500 $0.00
Grayzel David S
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 16,363 $2.75 44,998
Lundberg Sven Ante
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 20,363 $2.75 55,998
Laporte Kathleen
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 23,272 $2.75 63,998
Morrison Jodie Pope
Common Stock
2025-12-02 Sell 22,506 $3.46 77,871
Kalowski Lee
Common Stock
2025-12-02 Sell 9,072 $3.46 31,389
Tzianabos Arthur
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Iwicki Mark T
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Manke Isaac
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Xu Diyong
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Grayzel David S
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Thistle Mary
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Lundberg Sven Ante
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Laporte Kathleen
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 53,521 $0.00
Common Stock
2025-08-26 Sell 2,990 $1.80 5,382
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 53 9,428,899
2025-12-31 52 8,043,910
2025-09-30 53 8,428,833
2025-06-30 62 8,993,326
2025-03-31 75 9,407,169
2024-12-31 94 11,046,417
2024-09-30 74 9,112,107
2024-06-30 55 8,068,108
2024-03-31 39 7,432,932
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com